Ghavami Maryam, Li Haibo, Liu Lixuan, Butler Joshua H, Ding Sha, Butschek Grant J, Haney Reagan S, Council-Troche R McAlister, Grams R Justin, Merino Emilio F, Davis Jennifer M, Totrov Maxim, Cassera Maria B, Carlier Paul R
Department of Chemistry and Virginia Tech Center for Drug Discovery, Virginia Tech 1040 Drillfield Drive Blacksburg VA 24061 USA.
Department of Biochemistry and Molecular Biology and Center for Tropical and Emerging Global Diseases, University of Georgia 120 E. Green St. Athens GA 30602 USA.
RSC Med Chem. 2025 Aug 15. doi: 10.1039/d5md00439j.
Tetrahydro-β-carboline 1 (MMV008138) controls growth of asexual blood-stage by inhibiting IspD, an enzyme in the MEP pathway for synthesis of a critical metabolite, isopentenyl pyrophosphate (IPP). We have previously investigated the structure activity relationship (SAR) of three of its four rings (B, C, and D). In this report we investigate the SAR of the benzo- ( A-ring) of 1, with the goal of increasing its antimalarial potency and metabolic stability. As in our previous studies of the B- and C-ring substitution, extreme sensitivity to substitution was also seen in the benzo-ring. In total, 19 benzo-ring substitution variants of 1 were prepared. When tested against multidrug-resistant (Dd2 strain) , only three derivatives (20a, c, d) possessed asexual blood stage (ABS) activity with EC values within 3-fold of the parent. As hoped, one analog (20c) showed a marked improvement in microsomal stability. However, this improvement unfortunately did not improve plasma exposure relative to 1, and did not lead to oral efficacy in a mouse model of malaria.
四氢-β-咔啉1(MMV008138)通过抑制IspD来控制无性血液期的生长,IspD是甲羟戊酸途径中一种用于合成关键代谢物异戊烯基焦磷酸(IPP)的酶。我们之前已经研究了其四个环(B、C和D)中三个环的构效关系(SAR)。在本报告中,我们研究了1的苯并环(A环)的SAR,目的是提高其抗疟效力和代谢稳定性。正如我们之前对B环和C环取代的研究一样,苯并环对取代也表现出极高的敏感性。总共制备了1的19种苯并环取代变体。在针对多重耐药(Dd2株)进行测试时,只有三种衍生物(20a、c、d)具有无性血液期(ABS)活性,其EC值在母体的3倍以内。正如所期望的,一种类似物(20c)在微粒体稳定性方面有显著改善。然而,不幸的是,这种改善并没有提高相对于1的血浆暴露量,也没有在疟疾小鼠模型中产生口服疗效。